Business Context and Reporting Period
Company: MOOG INC.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: January 2, 2010
Business Overview: Moog Inc. is a worldwide designer, manufacturer, and integrator of high-performance precision motion and fluid controls for aerospace, defense, industrial, and medical markets. The company operates through five segments: Aircraft Controls, Space and Defense Controls, Industrial Systems, Components, and Medical Devices.
Key Financial Metrics
| Metric (in thousands) | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales | $495,178 | $446,088 |
| Gross Profit | $144,402 | $137,848 |
| Gross Margin | 29.2% | 30.9% |
| Net Earnings | $21,561 | $30,270 |
| Diluted EPS | $0.47 | $0.70 |
| Operating Cash Flow | $56,065 | $32,549 |
| Cash and Equivalents (End of Period) | $101,301 | $118,417 |
| Total Debt (Current + Long-Term) | $796,132 | $822,146 |
Note: Total Debt calculated as Notes Payable + Current Installments of Long-Term Debt + Senior Debt + Senior Subordinated Notes.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 11% ($49 million) compared to the first quarter of 2009. This growth was driven by $81 million in incremental sales from recent acquisitions, partially offset by the global recession's impact on organic sales, particularly in the Industrial Systems segment.
- Profitability Decline: Net earnings decreased 29% to $21.6 million. Diluted earnings per share fell 33% to $0.47, reflecting both lower net earnings and an increase in outstanding shares following a stock offering in October 2009.
- Margin Compression: Gross margin decreased to 29.2% from 30.9% due to a less favorable product mix and lower sales volume (excluding acquisitions), though this was partially offset by a $6 million reduction in contract loss reserve additions.
- Restructuring: The company incurred $1.8 million in restructuring expenses in Q1 2010, compared to none in the prior year period, as part of ongoing efforts to align costs with lower sales activity.
- Segment Performance:
- Aircraft Controls: Sales up 7%; Operating margin improved to 10.1% from 8.3%.
- Space and Defense: Sales down 3%; Operating margin dropped significantly to 10.8% from 19.0% due to lower volume on the Driver's Vision Enhancer program.
- Industrial Systems: Sales up 24% (driven by wind energy acquisitions); Operating margin declined to 8.2% from 10.5%.
- Medical Devices: Sales up 47%; Returned to profitability with a 0.5% margin after a loss in the prior year.
Guidance, Outlook, and Risks
2010 Outlook
- Sales: Expected to increase 15% to approximately $2.12 billion.
- Operating Margins: Projected at 9.6% (up from 9.3% in 2009).
- Net Earnings: Expected to increase to $103 million.
- Diluted EPS: Forecast to increase 14% to $2.25 (range of +/- $0.10).
- Restructuring Costs: Estimated at $6 million for the full year 2010.
Management Commentary
Management attributes the sales increase to recent acquisitions, particularly in Industrial Systems (wind energy) and Aircraft Controls. However, the company continues to face challenges from the global recession, pricing pressures, and increased costs such as healthcare benefits. The company is focusing on cost improvements and strategic revenue growth.
Risks and Contingencies
- Goodwill Impairment: The fair value of the Aircraft Controls reporting unit is only 6% in excess of its carrying value, making it sensitive to program delays or economic pressures.
- Customer Concentration: Significant dependence on major customers like Boeing and Lockheed Martin.
- Government Contracts: Risk of contract termination or funding delays in defense and space sectors.
- Acquisition Integration: Risks associated with integrating recent acquisitions and potential unknown liabilities.
Investor Verification Checklist
- Acquisition Impact: Verify the sustainability of the $81 million sales contribution from recent acquisitions, specifically the wind energy (LTi REEnergy, Insensys) and flight control (GE Aviation) businesses.
- Goodwill Valuation: Monitor the Aircraft Controls segment closely, as its fair value is only slightly above carrying value, posing a risk of future impairment charges.
- Debt Covenants: Confirm continued compliance with credit facility covenants, specifically the maximum leverage ratio (4.0) and minimum interest coverage ratio (3.0), given the company's debt levels.
- Medical Segment Turnaround: Assess whether the Medical Devices segment can sustain profitability beyond the one-time reserve release in the prior year.
- EPS Dilution: Evaluate the long-term impact of the October 2009 stock offering on future earnings per share growth targets.